LC
AMGN icon

Lourd Capital’s Amgen AMGN Stock Holding History

Lourd Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,807
Closed -$352K – 136
2018
Q4 		$352K Sell
1,807
-17
-0.9% -$3.32K 0.03% 166
2018
Q3 		$378K Buy
+1,824
New +$359K 0.02% 173
2018
Q1 		– Sell
-1,806
Closed -$314K – 128
2017
Q4 		$314K Buy
+1,806
New +$320K 0.02% 225

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lourd Capital's AMGN Position: Q1 2019 in Review

Lourd Capital sold out of Amgen (AMGN) in Q1 2019, closing a stake of 1,807 shares — an estimated $352K sold.

Lourd Capital first reported a position in AMGN in Q4 2017 and held it in 3 quarters. The position peaked at $378K in Q3 2018. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Lourd Capital reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Lourd Capital sold 1,807 Amgen shares in Q1 2019, an estimated $352K.
  • Lourd Capital first reported a position in Amgen in Q4 2017 and held it in 3 quarters.
  • Lourd Capital's Amgen position peaked at $378K in Q3 2018.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Lourd Capital's 13F filing for Q1 2019, filed 16 Apr 2019.